ARMs: Applications to reclassify medicines consultation letters

This change enables applications to be dealt with faster by removing the need to amend statutory orders. In designing the new reclassification procedures, we took the opportunity to introduce changes to how we consult - some of which were set out in the consultation document MLX 279. Respondents to MLX 279 broadly welcomed the proposed changes to the consultation process. As each application will merit its own consultation, with a dedicated timetable, we will not be using the MLX prefix for reclassification consultations but rather a dedicated prefix - 'ARM' (application to reclassify a medicine).

Contact for further information
For further information on ARMs , please contact our Reclassification Unit, 14-1, MHRA, Market Towers, 1 Nine Elms Lane, London SW8 5NQ, telephone 020 7084 2523, fax 020 7084 2293 or e-mail our Central Enquiry Point.

Latest ARMs

• 31 Jul 2008| Public consultation ARM 54: Request to reclassify a bottle presentation of Calpol Six Plus Suspension Sugar Free from Pharmacy (P) to General Sales List (GSL)

  Reminder: Closing date for comments is 6 August 2008.
  ARM 54 seeks your views on the reclassification from P to GSL of a bottle presentation of Calpol Six Plus Suspension Sugar Free.

• 09 Apr 2008| Public consultation ARM 53: Request to reclassify Nicorette 25mg patch from Pharmacy (P) to General Sales List (GSL)

  Consultation ARM 53 seeks your views on the reclassification from P to GSL of Nicorette 25mg Patch.

• 04 Apr 2008| Public consultation ARM 52: Request to reclassify Voltarol Pain-Eze Emulgel from Pharmacy (P) to General Sales List (GSL)

  ARM 52 seeks your views on the reclassification of Voltarol Pain-Eze Emulgel from Pharmacy (P) to General Sales List (GSL). A reminder that comments should arrive by 8 April 2008

• 04 Mar 2008| Public consultation ARM 51: Request to reclassify Cystobid 100mg Capsules from prescription only medicine (POM) to pharmacy availability (P)

  Consultation ARM 51 seeks your views on the reclassification of Cystobid 100 mg Capsules from prescription only medicine (POM) to pharmacy availability (P).

• 04 Dec 2007| Public consultation ARM 50: Request to reclassify Nicorette Inhalator from Pharmacy (P) to General Sale List (GSL)

  ARM 50 seeks your views on the reclassification of Nicorette Inhalator from Pharmacy (P) to General Sale List (GSL).
  

• 19 Nov 2007| Public consultation ARM 49: Request to reclassify Voltarol Pain-eze tablets from prescription only medicine (POM) to pharmacy availability (P)

  Consultation ARM 49 seeks your views on the reclassification of Voltarol Pain-eze tablets from prescription only medicine (POM) to pharmacy availability (P).

• 16 Nov 2007| Public consultation ARM 48: Request to reclassify Galpharm Four in One Flu Relief from P (Pharmacy) to GSL (General Sales List)

  Consultation ARM 48 seeks your views on the reclassification of Galpharm Four in One Flu Relief from P (Pharmacy) to GSL (General Sales List).

• 11 Oct 2007| Public consultation ARM 45: Request to reclassify 12-sachet packs of Calpol Six Plus Sugar Free Suspension from P (Pharmacy) to GSL (General Sales List)

  Consultation ARM 45 seeks your views on the reclassification from P to GSL of a 12-sachet pack of Calpol Six Plus Sugar Free Suspension.

• 20 Aug 2007| Public consultation ARM 44: Request to reclassify Galpharm Hayfever Eye drops containing sodium cromoglicate 2% from Pharmacy (P) to General Sales List (GSL)

  Consultation ARM 44 seeks your views on the reclassification of Galpharm Hayfever Eye drops containing sodium cromoglicate 2% from P to GSL.

• 21 Jun 2007| Public consultation ARM 43: Request to reclassify azithromycin 500mg from POM (prescription only medicine) to P (Pharmacy)

  Consultation ARM 43 sought your views on the reclassification from POM (prescription only medicine) to P (Pharmacy) of azithromycin 500mg.